Updated, June 27, 2007
Senior Oncologist
Department of Oncology
Hadassah University Hospital
Jerusalem, Israel.
Telephone: 972-2-9993531
Mobile phone: 972-508-573604
Date of birth: 21.12.63
Repatriation: 1991
Marital status: Married + 2 children
Nationality:Israeli
Address: Hartuv St.18/5 , Beit-Shemesh, Israel
Education
1971-1979 Elementary School, Saratov, Russia.
1979-1981 High School, Saratov, Russia.
1981-1987 M.D. - State Medical Institute, (University) of Saratov, Russia.
1990 - Specialized course and training in clinical Radiology, State Medical Institute, (University) of Saratov, Russia
1991-1992 Qualification course for Foreign physicians – by Israel Ministry of Health.
Examinations
Board Exam in Radiation and Medical Oncology, Stage I.
Board Exam in Radiation and Medical Oncology, Stage II.
Employment
1987-1988 Internship, Regional Hospital, Tambov, Russia.
1988-1989 General Practitioner, General Outpatient Clinic, Tambov, Russia.
1992-1993 Resident, Internal Medicine Department, Shaare-Zedek Hospital, Jerusalem, Israel
5.93-11.94 Military Service in IDF -Medical Officer.
1994 -2004 Resident, Oncology Department, Hadassah University Hospital, Jerusalem, Israel.
2004-present Senior Oncologist, Hadassah University Hospital, Jerusalem, Israel.
Publications
Original papers:
1. Treatment of pathological humeral shaft fractures with unreamed humeral nail. 2007 Apr;14(4):1493-8. Epub 2007 Jan 9. K. Atesok; E. Sucher; M. Temper*; and A. Peyser
Abstracts:
1. Continuous Infusion (CI) of 5-Fluorouracil (5-FU) and Oral Leucovorin (LCV) in the Treatment of Metastatic Breast Cancer (MBC). O. Lyass, M. Temper, G. Brufman, A. Gabizon, A. Hubert, T. Peretz, B. Uziely: ECCO, 1999.
2. Male Breast Cancer – The Hadassah Experience. M. Temper, M. Gips, T. Hamburger, L. Divinsky, T. Peretz, ISCORT, Eilat 2003.
3. The Contribution of BRCA1 and BRCA2 Mutations in morbidity of Malignant Melanoma in an Ashkenazi Population. M. Temper, T. Greanader, L. Kadouri, T. Peretz.ISCORT, Eilat 2005.
4. Zoledronic acid induced elevation of serum parathyroid hormone (PTH) levels.
T. Grenader, L. Shavit, M. Temper, B. Uziely. ISCORT, Eilat 2005. |